Tetra Bio-Pharma’s Dr. Chamberland Goes to Washington!

ORLEANS, Ontario, Nov. 26, 2018 (GLOBE NEWSWIRE) — Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the market that Dr. Guy Chamberland, CEO and CSO of Tetra Bio-Pharma will be travelling to Washington, D.C. today for individual meetings with six high-ranking U.S. Senators.

The meetings, scheduled for November 26th and 27th, have a mutually beneficial purpose, namely expanding Tetra’s existing work with Health Canada and the FDA in the United States as well as briefing the Senators on Tetra Bio-Pharma’s unique approach which combines the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

Tetra Bio-Pharma is the only company in North America, in addition to GW Pharmaceuticals, to work with both the FDA and Health Canada on clinical trial

... read more at: https://www.apnews.com/3c7395a969fc1e41d0a0bb2d9545f534